Hydration and Acceptability of the Genital and Skin Mucosa of a Vaginal Moisturizer in Menopausal Women

Inclusion Criteria:

• Healthy research participants, with an active sexual life;

• Intact skin and mucosa in the test region;

• Participants vaccinated for COVID-19 (Corona virus Disease).

• Agreement to adhere to the study procedures and requirements and attend theinstitute on the day(s) and time(s) determined for the assessments;

• Ability to consent to participate in the study;

• Menopausal participants of any age, without systemic or topical hormone replacementtherapy in the last 6 months

• Presenting mild to moderate vaginal dryness (≥0.5 and <7.5) - according to theVisual Analogic Scale

• Healthy research participants, with an active sex life (at least once a week)

Exclusion Criteria:

• Skin pathology in the area of product application;

• Decompensated Diabetes Mellitus (TBD by the institute together with the sponsor);

• Immune insufficiency;

• Current use of the following topical or systemic medications: corticosteroids,immunosuppressants and antihistamines;

• Skin diseases: vitiligo, psoriasis, atopic dermatitis;

• Previous reaction to the category of the product tested;

• Other illnesses or medications that may directly interfere with the study or put thehealth of the research participant at risk.

• Have used vaginal moisturizing creams and/or intimate lubricants 5 days before theinitial study visit;

• Have had sexual intercourse at least 48 hours before the initial study visit;

• Have been diagnosed with a urogenital or vaginal infection in the last 30 days;

• Have used topical or systemic antibiotics, antifungals, hormone-based creams ortreatment for vaginal atrophy in the last 30 days.